Research paper co-authored by Dr. Georgi Abraham in October 2025
This is a research paper co-authored by TANKER Foundation Founder Trustee, Dr. Georgi Abraham, for the ‘Journal of Clinical Gastroenterology and Hepatology Research’, published on October 22, 2025.
TITLE:
Prevalence of MASLD in End-Stage Kidney Disease Patients and Evaluation of Tocotrienol as a Therapeutic Agent – PMET Study
Abraham G, Jayaraman GV, Mathew M, Prakash A and Kumaraswamy L
Abstract:
Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly termed Non-Alcoholic Fatty Liver Disease (NAFLD), is increasingly recognized among patients with End-Stage Kidney Disease (ESKD) undergoing dialysis. However, data on the prevalence of MASLD in ESKD patients in India is currently unavailable. Diagnostic challenges and limited therapeutic options further complicate its management in this population. The American Association for the Study of Liver Diseases (AASLD) recommends lifestyle modification and vitamin E for MASLD, particularly in non-diabetic patients. This study aims to evaluate the prevalence of MASLD among ESKD patients in India and represents the first clinical evaluation of tocotrienol, a potent vitamin E isomer, as a potential therapeutic intervention in this group.
Research paper co-authored by Dr. Georgi Abraham
This is a research paper co-authored by TANKER Foundation Founder Trustee, Dr. Georgi Abraham, that appeared in the Journal of Renal Nutrition and Metabolism issue of July-December 2023.
TITLE:
Evaluation of Proteolytic Enzyme on Hemodialysis Patients with Protein–Energy Wasting and Associated Variables
Abstract:
Protein–energy wasting (PEW) is very commonly seen among hemodialysis (HD) patients. This study was carried out to estimate the nutrition status of HD patients receiving aminase tablets, a proteolytic enzyme with a high‐protein diet, for reducing PEW.